Moreover, we have compared TZM‐HER2 binding levels using MFLI FRET and IHC imaging across tumors ranging from the periphery to the center and showed a distinct distribution of tumor‐bound TZM across whole AU565 versus SKOV‐3 tumors. Here, ERBB2 is linked to neoplasm.